Patient info

Ursodeoxycholic Acid Glenmark 250 mg hard capsule – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
250 mg
Contains active substance:

Patient leaflet - Ursodeoxycholic Acid Glenmark 250 mg hard capsule

1. What Ursodeoxycholic Acid is and what it is used for

Ursodeoxycholic acid (UDCA), the active substance from Ursodeoxycholic Acid is a bile acid produced naturally, which is found in small amounts in human bile.

Ursodeoxycholic Acid is used for:

  • for the treatment of a condition where the bile ducts in the liver

    become damaged leading to a build-up of bile. This may cause scarring of the liver. The liver should not be so damaged that it is not functioning properly. This condition is called primary biliary cirrhosis

  • to dissolve gallstones caused by excess cholesterol in the gall

    bladder (in patients for whom surgery is not an option), where the gallstones are not visible on a plain x-ray (gallstones that are visible will not dissolve) and not more than 15 mm in diameter. The gall bladder should still be working despite the gallstone(s)

  • for liver disease associated with a condition called cystic fibrosis

    in children 6 to 18 years.

2. What you need to know before you use Ursodeoxycholic Acid

Do not use Ursodeoxycholic Acid:

  • If you are allergic to bile acids like UDCA or any of the other

    ingredients of this medicine (listed in section 6).

  • If you have an acute inflammation of the gall bladder or biliary

    tract.

  • If you have a blockage of the common bile duct or cystic duct

    (obstruction of the biliary tract).

  • If you have frequent cramp-like upper abdomen pain (biliary

    colic).

  • If your doctor has said you have calcified gallstones.
  • If you have an insufficiency of the contractility of the gall bladder.
  • If you are or have a child with biliary atresia or has poor bile flow

    even after surgery.

Please ask your doctor about the conditions mentioned above. You should also ask if you have previously had any of these conditions. Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Ursodeoxycholic Acid. Ursodeoxycholic Acid should be administered under medical supervision.

Your doctor should test your liver function regularly every 4 weeks for the first 3 months of treatment. After this time, it should be monitored at 3 month intervals.

When used to dissolve gallstones, your doctor should arrange for a scan of your gall bladder after the first 6-10 months of treatment. Talk to your doctor immediately if you have diarrhoea, as this may require a reduction in the dose or discontinuation of the treatment with Ursodeoxycholic Acid.

If you suffer from primary biliary cirrhosis and your symptoms get worse at the beginning of the treatment a reduction in the dose may be required and gradually increased again as described in section 3 (How to take Ursodeoxycholic Acid).

If you are a woman of childbearing potential you must use contraception. Non-hormonal or oral contraceptives containing small amounts of estrogen are recommended. However, if you take Ursodeoxycholic Acid for dissolve gallstones, you should use non-hormonal contraception because hormonal contraceptives may increase gallstone risk.

Other medicines and Ursodeoxycholic Acid

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those without medical prescription. Treatment with Ursodeoxycholic Acid may still be allowed. Your doctor will know what is right for you.

A reduction in the effects of the following medicines is possible when taking Ursodeoxycholic Acid:

  • colestyramine, colestipol (to lower blood lipids) or antacids

    (drugs that bind hydrochloric acid in the gastric juice) containing aluminium hydroxide or smectite (aluminium oxide). If you must take medication that contains any of these ingredients, it must be taken at least two hours before or after Ursodeoxycholic Acid.

  • rosuvastatin (used to lower blood lipids). It may be necessary for your doctor to alter the dose of these medicines.
  • ciprofloxacin, dapsone (antibiotics), nitrendipine (used to treat high blood pressure) and other medicines which are metabolised in a similar way. It may be necessary for your doctor to alter the dose of these medicines.

Ursodeoxycholic Acid may increase the effects of the following medicines:

  • ciclosporin (to reduce the activity of the immune system). If you are being treated with ciclosporin, your doctor should check the amount of ciclosporin in your blood. Your doctor will adjust its dose, if necessary.

If you are taking Ursodeoxycholic Acid for the dissolution of gallstones, please inform your doctor in case you are taking any medicines that contain oestrogenic hormones or blood cholesterol lowering agents such as clofibrate. These medicines stimulate the formation of gallstones, which is a counter-effect to the treatment with Ursodeoxycholic Acid.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

You should not take Ursodeoxycholic Acid during pregnancy unless your doctor thinks it is absolutely necessary. The use of Ursodeoxycholic Acid during the first 3 months of pregnancy may cause foetal harm.

Check that you are not pregnant before taking this medicine Women of child-bearing potential

Even if you are not pregnant you should talk to your doctor because women of childbearing potential must use contraception. Non-hormonal or oral contraceptives containing small amounts of estrogen are recommended. However, if you take Ursodeoxycholic Acid for dissolve

gallstones, you should use non-hormonal contraception because hormonal contraceptives may increase gallstone risk. Your doctor must exclude the possibility of a pregnancy before beginning of treatment.

Breastfeeding

You should not take Ursodeoxycholic Acid during breast-feeding. It is not known whether Ursodeoxycholic Acid passes into breast milk. If treatment with Ursodeoxycholic Acid is absolutely necessary, you should stop breastfeeding.

Driving and using machines

Ursodeoxycholic Acid has no or negligible influence on the ability to drive and use machines.

3. How to take Ursodeoxycholic Acid

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The daily dose is determined by therapeutic indication. For the treatment of the of primary biliary cirrhosis (PBC) The recommended daily dose will be determined by the doctor based on body weight and is between 3 to 7 hard capsules of Ursodeoxycholic Acid (12 – 16 mg of UDCA per kg of body weight per day).

During the first 3 months of treatment you should take Ursodeoxycholic Acid in the morning, to midday and evening. The recommended treatment schedule is as follows:

Body

weight

(kg)

Daily dose

(mg/ kg of body

weight) Morning Midday Evening

47 – 62 kg 12-16 1 1 1

63 – 78 kg 13-16 1 1 2 79 – 93 kg 13-16 1 2 2 94 – 109 kg 14-16 2 2 2 Over 110 kg 7 hard capsules 2 2 3

With improvement of the liver values your doctor will advise to take the daily dose once daily in the evening.

The use of Ursodeoxycholic Acid in primary biliary cirrhosis may be continued indefinitely.

For dissolution of cholesterol gallstones:

Adults: The usual dose is 8–12 mg/ ursodeoxycholic acid (UDCA) per kg body weight per day, taken in the evening before bedtime according to:

  • up to 60 kg: 2 capsules
  • 61-80 kg: 3 capsules
  • 81-100 kg: 4 capsules
  • above 100 kg: 5 capsules

Care should be taken to ensure that they are taken regular. In general, the time required for dissolution of gallstones is generally 6-24 months, depending on stone size and composition. Every 6 months the doctor will check the effectiveness of treatment (reduction in size until such calculi) by radiographic examination (cholecystography) or ultrasound.

Your doctor may stop treatment unless noted a reduction in the size of gallstones after 2 cholecystography and/or successive ultrasound.

For children with cystic fibrosis aged 6 years to less than 18 years The recommended dose is 20mg per kg of body weight daily taken in 2 or 3 divided doses. It may be increased if necessary to 30mg per kg of body weight daily.

Body

weight BW

(kg)

Daily dose

(mg/kg

BW)

Ursodesoxycholic Acid 250mg capsules

Morning Midday Evening

20-29 17-25 1 - 1 30-39 19-25 1 1 1 40-49 20-25 1 1 2 50-59 21-25 1 2 2 60-69 22-25 2 2 2 70-79 22-25 2 2 3 80-89 22-25 2 3 3 90-99 23-25 3 3 3 100-109 23-25 3 3 4 >110 3 4 4

Take the capsules two to three times a day as advised for your doctor or pharmacist. Take the capsules regularly.

How to use Ursodeoxycholic Acid

Swallow the capsules whole with a glass of water. Elderly

There is no evidence to suggest that any alteration in the adult dose is needed.

Use in children and adolescents

Cholesterol rich gallstones are very rare in children but when they occur, dosage should be related to bodyweight and medical conditions.

There is no age limit for ursodeoxycholic acid administration, the active ingredient of Ursodeoxycholic Acid. If the patient cannot swallow capsules or has a bodyweight below 47 kg, other pharmaceutical forms (suspension) are available.

If you take more Ursodeoxycholic Acid than you should

Diarrhoea may occur as a result of overdose. Please inform your doctor immediately if you have persistent diarrhoea. Make sure you drink enough liquids to replace your fluid and salt balance. If you forget to take Ursodeoxycholic Acid

Do not take more doses the next time, but just continue the treatment with the prescribed dose. Do not take a double dose to make up for a forgotten dose.

If you stop taking Ursodeoxycholic Acid

Always speak to your doctor before you decide to interrupt treatment with Ursodeoxycholic Acid or decide to stop your treatment early.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact your doctor immediately if you experience any of the following symptoms after taking Ursodeoxycholic Acid: Common side effects (may affect up to 1 in 10 people):

  • soft, loose stools or diarrhoea. Inform your doctor immediately

    if you have persistent diarrhoea, as this may require a reduction in the dose of your medicine. If you do suffer from diarrhoea, make sure you drink enough liquids to replace your fluid and salt balance.

Very rare side effects (may affect up to 1 in 10,000 people):

  • during the treatment of primary biliary cirrhosis: severe right-

    sided upper abdominal pain, severe worsening of liver cirrhosis which partially eases after treatment is discontinued

  • hardening of gallstones due to build-up of calcium
  • nettle rash (urticaria)

    Reporting of side effects

    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard.

    By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Ursodeoxycholic Acid

Keep this medicine out of the sight and reach of children. The medicinal product does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Ursodeoxycholic Acid contains

  • The active substance is ursodeoxycholic acid.
  • The other ingredients are: hard capsule contents: StarCap

    (maize starch, pregelatinized starch), crospovidone (E1202), sodium lauryl sulphate, silica colloidal anhydrous, magnesium stearate (E572), capsule: gelatine (E441), sunset yellow (E110), titanium dioxide (E171).

What Ursodeoxycholic Acid looks like and contents of the pack

Hard gelatin capsules, orange, containing white or almost white granules.

Box of 3 blisters packs PVC-PVDC/Aluminium, each containing 10 hard capsules.

Box of 5 blisters packs PVC-PVDC/Aluminium, each containing 10 hard capsules.

Box of 3 blisters packs PVC-PVDC/Aluminium, each containing 20 hard capsules.

Box of 5 blisters packs PVC-PVDC/Aluminium, each containing 20 hard capsules.

Box of 10 blisters packs PVC-PVDC/Aluminium, each containing 20 hard capsules.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Glenmark Pharmaceuticals Europe Limited

Laxmi House

2B Draycott Avenue

Kenton, Middlesex

HA3 0BU

United Kingdom

Manufacturer

Glenmark Pharmaceuticals s.r.o.

Hvězdova 1716/2b

Prague 4, 140 78

Czech Republic

Site Address:

Glenmark Pharmaceuticals s.r.o.

Fibichova 143

Vysoké Mýto, 566 17

Czech Republic

Or

Vitema S.A.

156 Alba Iulia Highway

550052-Sibiu, Sibiu County

Romania

This leaflet was last revised in August 2024

PRODUCT: Amends: Approval:

Indesign CS 6

GM1867

Ursodeoxycholic acid 250mg

Hard caps

5.10.22

197x350 mm

2

19.6.24

Leaflet (PIL)

Y

Times New Roman ALL 9 pts body copy (min)

Internal proof approval

External proof approval Signed (digitally)

Signed (digitally)

off (digitally):

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 25258/0204

Last revision stated in the text: August 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ursodeoxycholic Acid Glenmark 250 mg hard capsule

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Ursodeoxycholic acid
Strength 250 mg
Pharmaceutical form Oral capsule
Hard gelatin capsules with 2 tightly closed parts (cap and body) orange-opaque colour, size 0, about 21.4 mm containing white or almost white granular powder.
How is it taken Oral
Excipients StarCap 1500 (maize starch, pregelatinized starch), Crosspovidone (E1202), Sodium lauryl sulphate, Colloidal silicon dioxide, anhydrous, Magnesium stearate (E572), Gelatine (E441), Sunset Yellow (E110), Titanium dioxide (E171)
Pack sizes 60 capsule
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months
Storage The medicinal product does not require any special storage conditions.
Drug group (ATC) Therapy gallbladder, bile acid preparations
  1. A Alimentary tract and metabolism drugs
    1. A05 Bile and liver therapy drugs
      1. A05A Bile therapy drugs
        1. A05AA Bile acids and derivatives for bile therapy
          1. A05AA02 ursodeoxycholic acid
Marketing authorisation PL 25258/0204 (first authorised 28 September 2021)
Marketing authorisation holder Glenmark Pharmaceuticals Europe Limited
Codes GTIN 5060204164699 · BNF 01090100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.